Otto A Smiseth1. 1. Division of Cardiovascular and Pulmonary Diseases, Department of Cardiology and Institute for Surgical Research, Center for Heart Failure Research and KG Jebsen Cardiac Research Centre Oslo, Oslo University Hospital, University of Oslo, Rikshospitalet, N-0027 Oslo, Norway osmiseth@ous-hf.no otto.smiseth@rikshospitalet.no o.a.smiseth@medisin.uio.no.
Routine echocardiographic evaluation of left ventricular (LV) diastolic function includes measurement of mitral flow velocities, mitral annular velocities, and left atrial (LA) volume. Based on patterns of mitral filling, diastolic dysfunction is traditionally quantified as mild (Grade I), moderate (Grade II), and severe (Grade III).[1] A problem with defining Grade II is that this mitral filling pattern is similar to that in normal hearts (pseudonormal) and was considered ‘the Achilles heel of diastology’. With the introduction of tissue Doppler, it became possible to measure mitral annular velocities, and peak early-diastolic LV lengthening velocity (e′), which reflects myocardial relaxation and restoring forces,[2] is now a key parameter when evaluating diastolic function. In patients with Grade II diastolic dysfunction, there is typically reduced peak early-diastolic velocity (e′) or signs of moderate elevation of LV filling pressure.[1] One problem when using e′ to differentiate between Grade II and normal filling, however, is the wide normal range for e′ which is between ∼6 and16 cm/s in apparently healthy middle-aged individuals.[3,4] Therefore, additional measures such as abnormalities in pulmonary venous flow velocity are needed.[5]
Figure shows a pulmonary venous flow velocity trace recorded by Doppler echocardiography.A typical pulmonary venous flow velocity trace with a systolic wave which has an early-systolic component (S1) and a larger mid- and late-systolic component (S2), followed by a diastolic component (D). During atrial contraction, there is slight flow reversal (Ar).In this study, Buffle et al.[6] present data on the additive prognostic value of pulmonary venous velocities when measured, in addition to mitral early (E) and atrial-induced (A) velocities, e′, the E/e′ ratio, and LA volume. The study population included patients with EF >50% who were admitted to the hospital for various cardiac and non-cardiac causes. In this group of patients, the best pulmonary vein predictor of the combined event rate was the ratio of pulmonary venous systolic to diastolic flow velocity-time integral, whereas the ratio between the peak systolic and diastolic velocities (S/D ratio) was the best predictor of heart failure readmissions. Increasing difference between the duration of Ar and mitral A velocity was also associated with heart failure readmissions. Furthermore, they showed that Grade II diastolic function with a peak S/D ratio of <1 had a markedly higher rate of admission for heart failure and a higher combined event rate than patients with Grade I, whereas there was no difference for Grade II with an S/D ratio of >1. The S/D ratio remained an independent predictor for survival when adjusted for LA volume index and E/e′. These results suggest that the pulmonary venous S/D ratio or the ratio between the velocity-time integrals may provide prognostic information beyond the traditional grading of diastolic function into mild, moderate, and severe.Recordings of LA and LV pressures along with pulmonary venous flow. Intraoperative measurements from a patient prior to coronary bypass surgery. The pulmonary flow trace resembles an inverted LA pressure trace. Reproduced with permission from Smiseth and Thompson.[7]The aetiology of the systolic pulmonary venous flow wave (S) has been debated. One theory has been that the S is caused by the early-systolic fall in LA pressure due to atrial relaxation and descent of the atrioventricular (AV) plane. Figure illustrates that onset of the S wave coincides with fall in LA pressure. Another theory has been that the S is due to transpulmonary propagation of the right ventricular (RV) pressure pulse. In the study which utilized wave intensity analysis (Figure ), it was shown that the early-systolic flow wave (S1) is caused by atrial pressure decay, whereas the mid and late-systolic flow wave (S2) is caused predominantly by the RV pressure pulse and with an important contribution from systolic descent of the AV plane.[8] This implies that reduction in the pulmonary venous S wave may be due to reduced LV contractility since this reduces systolic descent of the AV plane. Furthermore, reduction in RV contractility is expected to reduce the RV pressure pulse, which pushes the blood forward in the pulmonary veins. Finally, atrial dysfunction may contribute due to reduced S wave due to a reduced rise in LA pressure during atrial contraction and therefore a smaller decline in pressure during atrial relaxation. Therefore, the observation that a reduced S/D ratio predicts cardiovascular events may be a reflection of reduction in left- or right-sided ventricular function and atrial function, and therefore is a relatively non-specific marker of cardiac dysfunction.Wave intensity analysis of pulmonary venous flow: the two upper panels show pulmonary venous pressure by micromanometer and velocity by flowmeter. Wave intensity is calculated as the product of instantaneous change in pressure (dP) and change in velocity (dU), and a negative product means a net backward-going wave and vice versa. Negative dP× dU in early systole (1) is attributed to decline in pressure due to atrial relaxation and systolic descent of the AV plane that acts like a suction force which ‘pulls’ blood into the left atrium, causing S1. The subsequent positive dP× dU (2) reflects a net forward-going wave caused by the RV pressure pulse, which ‘pushes’ blood towards the left atrium and contributes to S2. Modified from Smiseth et al.[8]In the study of Buffle et al.,[6] pulmonary venous systolic and diastolic velocities could be measured in 73% of the patients and duration of reversed atrial-induced velocity in 65%. This implies that image quality is a problem in a significant fraction of the patients. Therefore, pulmonary vein indices should be considered only one of the several possible indices to identify ‘true’ Grade II diastolic dysfunction. Other important variables which are associated with elevated LV filling pressure include enlarged left atrium, LV hypertrophy, increased E/e′ ratio, and elevated pulmonary artery systolic pressure estimated from the tricuspid regurgitation velocity. Possibly using two or three of the other non-invasive markers of elevated LV filling pressure may give similar information as pulmonary venous S/D ratio. The pulmonary S/D ratio is also used for assessing LV filling pressure,[9] but factors other than pressure modify the S/D relationship, and therefore is recommended just as a supplementary and not a stand-alone method in this context.[1] It is important to be aware that in young healthy subjects with normal diastolic function, the S/D ratio may be <1, but a noticeable Ar is absent. There is a need for more studies to determine how evaluation of pulmonary venous velocities can be better integrated into clinical decision-making.
Funding
Funding to pay the Open Access publication charges for this article was provided by University of Oslo, Institute of Clinical Medicine.
Authors: Anders Opdahl; Espen W Remme; Thomas Helle-Valle; Erik Lyseggen; Trond Vartdal; Eirik Pettersen; Thor Edvardsen; Otto A Smiseth Journal: Circulation Date: 2009-05-04 Impact factor: 29.690
Authors: Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa Journal: Eur J Echocardiogr Date: 2009-03
Authors: H F Kuecherer; I A Muhiudeen; F M Kusumoto; E Lee; L E Moulinier; M K Cahalan; N B Schiller Journal: Circulation Date: 1990-10 Impact factor: 29.690
Authors: Luis Caballero; Seisyou Kou; Raluca Dulgheru; Natalia Gonjilashvili; George D Athanassopoulos; Daniele Barone; Monica Baroni; Nuno Cardim; Jose Juan Gomez de Diego; Maria Jose Oliva; Andreas Hagendorff; Krasimira Hristova; Teresa Lopez; Julien Magne; Christophe Martinez; Gonzalo de la Morena; Bogdan A Popescu; Martin Penicka; Tolga Ozyigit; Jose David Rodrigo Carbonero; Alessandro Salustri; Nico Van De Veire; Ralph Stephan Von Bardeleben; Dragos Vinereanu; Jens-Uwe Voigt; Jose Luis Zamorano; Anne Bernard; Erwan Donal; Roberto M Lang; Luigi P Badano; Patrizio Lancellotti Journal: Eur Heart J Cardiovasc Imaging Date: 2015-04-20 Impact factor: 6.875
Authors: O A Smiseth; C R Thompson; K Lohavanichbutr; H Ling; J G Abel; R T Miyagishima; S V Lichtenstein; J Bowering Journal: J Am Coll Cardiol Date: 1999-09 Impact factor: 24.094
Authors: Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer Journal: JAMA Date: 2003-01-08 Impact factor: 56.272